SALUS DISCOVERY LLC
Madison, WI · Medtech · Private
Point-of-care immunoassay for detecting circulating anodic antigen (CAA) in urine to diagnose schistosomiasis infections
salusd.com →- Grants
- $12M
- 21 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- $299K
- 1 award · Health and Human S
- #424 of 4531 in medtech
- Patents
- 19
- 6 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2015201720192021202320252027
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Getting More from Less: Multi-omic Capture and Analysis from Patient Samples | $240,747 | |
| Federal contract | Department of Health and Human Services · Igf::ot::igf The Microvoa: Enhancing The Viral Outgrowth Assay (voa) With Microtechnology | $298,743 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Seeing the unseen: Enhancing purification of labile protein complexes and cells with low surface marker expression | $700,000 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Seeing the unseen: Enhancing purification of labile protein complexes and cells with low surface marker expression | $350,000 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Getting More from Less: Multi-omic Capture and Analysis from Patient Samples | $1,068,815 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Getting More from Less: Multi-omic Capture and Analysis from Patient Samples | $535,014 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a cell based assay to assess antigen specific tolerance | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a cell based assay to assess antigen specific tolerance | $225,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Getting More from Less: Multi-omic Capture and Analysis from Patient Samples | $533,801 | |
| Federal grant | Department of Health and Human Services · Phase I · Seeing the unseen: Enhancing purification of labile protein complexes and cells with low surface marker expression | $350,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology | $436,366 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology | $962,850 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology | $962,850 | |
| Federal grant | Department of Health and Human Services · Phase I · Enhancing detection and mobile monitoring of schistosomiasis with urine-based analyte pre-concentration technology | $275,526 | |
| Federal grant | Department of Health and Human Services · Phase I · Enhancing detection and mobile monitoring of schistosomiasis with urine-based analyte pre-concentration technology | $275,526 | |
| Federal grant | Department of Health and Human Services · Phase II · Enhancing Pediatric Diagnosis of Tuberculosis with FLOW Technology | $818,507 | |
| Federal grant | Department of Health and Human Services · Phase I · 3STEP: A swab-seal-read, point-of-care nucleic acid test to address disparity in STI screening and prevention | $275,736 | |
| Federal grant | Department of Health and Human Services · Phase II · 3STEP: A swab-seal-read assay for tuberculosis and RIF resistance enabled by autonomous extraction technology | $295,893 | |
| Federal grant | Department of Health and Human Services · Phase II · Flow Direct: Next Generation Urine LFA for TB Diagnosis in Point-of-Care Settings | $300,000 | |
| Federal grant | Department of Health and Human Services · Phase II · 3STEP: A swab-seal-read assay for tuberculosis and RIF resistance enabled by autonomous extraction technology | $1,000,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Flow Direct: Next Generation Urine LFA for TB Diagnosis in Point-of-Care Settings | $916,195 | |
| Federal grant | Department of Health and Human Services · Phase II · 3STEP: A swab-seal-read assay for tuberculosis and RIF resistance enabled by autonomous extraction technology | $913,705 |
Federal grant · SBIR/STTRFederal contract · USAspending
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 421 | ESPER BIOSCIENCES INC | $300K | — |
| 422 | DARWIN BIOSCIENCES, INC. | $299K | — |
| 423 | SEVIDENT, INC. | $299K | — |
| 424 | SALUS DISCOVERY LLC | $299K | — |
| 425 | Focal Medical, Inc. | $298K | $6.4M |
| 426 | MGENUITY CORPORATION | $296K | — |
| 427 | Koronis Biomedical Technologies Corp. | $296K | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Devices And Methods For Vertical Flow-based Detection Of Analytesgranted
- Sample Concentration And Detection Systems And Methodsapplication
- Sample Concentration And Detection Systems And Methodsgranted
- Device For Facilitating The Isolation Of Targets From A Biological Samplegranted
- Lateral Flow Devices And Methodsapplication
- Lateral Flow Devices And Methodsapplication
- Magnetic Base For Collection And Release Of Paramagnetic Particlesgranted
- Method And Device For Disaggregation Via Heterogeneous Particlesgranted
- Magnetic Base For Collection And Release Of Paramagnetic Particlesgranted
- Sample Concentration And Detection Systems And Methodsapplication
- Devices And Methods For Vertical Flow-based Detection Of Analytesapplication
- Sample Concentration And Detection Systems And Methodsapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.